Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £48,517,560 of indicative cost of Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 11.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Oxford University Hospitals Nhs Ft | £6,654,480 |
| Guy's & St Thomas' Nhs Foundation Trust | £3,807,720 |
| Nottingham University Hospitals Trust | £2,965,200 |
| University Hospital Southampton Nhs Ft | £2,454,480 |
| University Hpls Of Leicester Nhs Trust | £2,428,440 |
| North Bristol Nhs Trust | £2,361,240 |
| Sheffield Teaching Hospitals Nhs Trust | £1,840,440 |
| Portsmouth Hospitals Nhs Trust | £1,827,000 |
| Hull And East Yorkshire Hpls Nhs Trust | £1,744,680 |
| Barts Health Nhs Trust | £1,554,840 |
The primary-care picture
Mepolizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Mepolizumab medicine page.